Status:
COMPLETED
Mind-body Resiliency Intervention for Fear of Cancer Recurrence
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Center for Complementary and Integrative Health (NCCIH)
Conditions:
Cancer
Coping Skills
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to test the feasibility of a virtual, group mind-body resiliency intervention adapted to target fear of recurrence (FOR) among cancer survivors.
Detailed Description
This is a randomized pilot feasibility trial (1:1 intervention versus usual care; a referral to community-based cancer survivor support group) that will use mixed methods (quantitative and qualitative...
Eligibility Criteria
Inclusion
- History of non-metastatic, localized, or regional solid or blood malignancy(ies)
- Completion of primary cancer treatment (i.e., radiation, surgery, chemotherapy) and/or current use of long-term maintenance hormonal or biologic therapy
- Age ≥18 years
- Elevated fear of recurrence (FCRI severity score ≥16)
- MGB/BIDMC Medical Record Number (MRN)
Exclusion
- Self-reported inability to speak and write in English
- Undertreated serious mental illness as defined by history of suicidality, psychosis, and/or psychiatric hospitalization in the past year
- Inability to access technology and/or sufficient internet to participate virtual groups sessions
Key Trial Info
Start Date :
July 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04876599
Start Date
July 9 2021
End Date
August 31 2023
Last Update
October 12 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusett General Hospital Cancer Center
Boston, Massachusetts, United States, 02114
2
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
3
Mass General at Emerson Hospital -- Bethke
Concord, Massachusetts, United States, 01742
4
Mass General/North Shore Cancer Center
Danvers, Massachusetts, United States, 01923